Terril Brothers, Inc. Bristol Myers Squibb CO Transaction History

Terril Brothers, Inc.

  • $297 Million
  • Q4 2024

A detailed history of Terril Brothers, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Terril Brothers, Inc. holds 158,188 shares of BMY stock, worth $9.47 Million. This represents 3.01% of its overall portfolio holdings.

Number of Shares
158,188
Previous 150,383 5.19%
Holding current value
$9.47 Million
Previous $7.78 Million 14.97%
% of portfolio
3.01%
Previous 2.79%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025
BUY
$51.92 - $59.94 $405,235 - $467,831
7,805 Added 5.19%
158,188 $8.95 Million
Q3 2024

Nov 04, 2024
SELL
$39.66 - $51.75 $34,900 - $45,540
-880 Reduced 0.58%
150,383 $7.78 Million
Q2 2024

Aug 09, 2024
SELL
$40.25 - $52.99 $3.81 Million - $5.01 Million
-94,545 Reduced 38.46%
151,263 $6.28 Million
Q1 2024

Apr 29, 2024
SELL
$47.98 - $54.4 $62,613 - $70,992
-1,305 Reduced 0.53%
245,808 $13.3 Million
Q4 2023

Feb 02, 2024
SELL
$48.48 - $57.85 $87,554 - $104,477
-1,806 Reduced 0.73%
247,113 $12.7 Million
Q3 2023

Nov 08, 2023
SELL
$57.89 - $64.73 $353,013 - $394,723
-6,098 Reduced 2.39%
248,919 $14.4 Million
Q2 2023

Aug 04, 2023
SELL
$63.71 - $70.74 $93,653 - $103,987
-1,470 Reduced 0.57%
255,017 $16.3 Million
Q1 2023

May 08, 2023
SELL
$65.71 - $74.53 $489,079 - $554,726
-7,443 Reduced 2.82%
256,487 $17.8 Million
Q4 2022

Jan 31, 2023
SELL
$68.48 - $81.09 $361,232 - $427,749
-5,275 Reduced 1.96%
263,930 $19 Million
Q3 2022

Nov 01, 2022
SELL
$0.13 - $76.84 $244 - $144,382
-1,879 Reduced 0.69%
269,205 $19.1 Million
Q2 2022

Aug 04, 2022
SELL
$72.62 - $79.98 $7.87 Million - $8.67 Million
-108,390 Reduced 28.56%
271,084 $20.9 Million
Q1 2022

May 10, 2022
SELL
$61.48 - $73.72 $590,208 - $707,712
-9,600 Reduced 2.47%
379,474 $27.7 Million
Q4 2021

Feb 07, 2022
SELL
$53.63 - $62.52 $364,308 - $424,698
-6,793 Reduced 1.72%
389,074 $24.3 Million
Q3 2021

Oct 29, 2021
SELL
$59.17 - $69.31 $607,675 - $711,813
-10,270 Reduced 2.53%
395,867 $23.4 Million
Q2 2021

Jul 27, 2021
SELL
$61.91 - $67.42 $514,781 - $560,597
-8,315 Reduced 2.01%
406,137 $27.1 Million
Q1 2021

Apr 23, 2021
SELL
$59.34 - $66.74 $831,353 - $935,027
-14,010 Reduced 3.27%
414,452 $26.2 Million
Q4 2020

Jan 28, 2021
SELL
$57.74 - $65.43 $740,804 - $839,466
-12,830 Reduced 2.91%
428,462 $26.6 Million
Q3 2020

Oct 28, 2020
SELL
$57.43 - $63.64 $575,735 - $637,991
-10,025 Reduced 2.22%
441,292 $26.6 Million
Q2 2020

Aug 04, 2020
BUY
$54.82 - $64.09 $883,040 - $1.03 Million
16,108 Added 3.7%
451,317 $26.5 Million
Q1 2020

May 12, 2020
SELL
$46.4 - $67.43 $457,272 - $664,522
-9,855 Reduced 2.21%
435,209 $24.3 Million
Q4 2019

Feb 05, 2020
SELL
$49.21 - $64.19 $634,415 - $827,537
-12,892 Reduced 2.82%
445,064 $28.6 Million
Q3 2019

Oct 25, 2019
SELL
$42.77 - $50.71 $273,642 - $324,442
-6,398 Reduced 1.38%
457,956 $23.2 Million
Q2 2019

Aug 05, 2019
SELL
$44.62 - $49.34 $278,651 - $308,128
-6,245 Reduced 1.33%
464,354 $21.1 Million
Q1 2019

Apr 29, 2019
SELL
$45.12 - $53.8 $987,676 - $1.18 Million
-21,890 Reduced 4.44%
470,599 $22.5 Million
Q4 2018

Feb 07, 2019
SELL
$48.76 - $63.23 $94,350 - $122,350
-1,935 Reduced 0.39%
492,489 $25.6 Million
Q3 2018

Oct 23, 2018
SELL
$55.19 - $62.25 $440,416 - $496,755
-7,980 Reduced 1.59%
494,424 $30.7 Million
Q2 2018

Aug 03, 2018
BUY
$50.53 - $62.98 $249,870 - $311,436
4,945 Added 0.99%
502,404 $27.8 Million
Q1 2018

May 03, 2018
SELL
$59.92 - $68.98 $487,449 - $561,152
-8,135 Reduced 1.61%
497,459 $31.5 Million
Q4 2017

Jan 23, 2018
SELL
$59.94 - $65.35 $173,526 - $189,188
-2,895 Reduced 0.57%
505,594 $31 Million
Q3 2017

Nov 07, 2017
BUY
$55.23 - $63.74 $28.1 Million - $32.4 Million
508,489
508,489 $32.4 Million

Others Institutions Holding BMY

# of Institutions
2,760
Shares Held
1.57B
Call Options Held
28M
Put Options Held
28.7M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $127B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Terril Brothers, Inc. Portfolio

Follow Terril Brothers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Terril Brothers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Terril Brothers, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email